富勒烯及其衍生物在核生物医学领域应用的研究现状

倪瑾 蔡建明 吴秋业

引用本文:
Citation:

富勒烯及其衍生物在核生物医学领域应用的研究现状

  • 基金项目:

    国家自然科学基金资助项目(30200069)

  • 中图分类号: R817.9

The research status of empty and metallofullerene derivatives for biological applications

  • CLC number: R817.9

  • 摘要: 富勒烯及其衍生物是一类具有独特物理化学特性的化合物,在生物医学领域有广泛的应用前景。介绍该类化合物的合成及制备,富勒烯笼外配合物的抗HIV病毒、断裂DNA和清除自由基等生物学活性,以及富勒烯金属包合物在核医学诊断中的应用研究。
  • [1] Nakamura E,Isobe H.Functioanlized fullerenes in water.The first 10 years of their chemistry,biology,and nanoscience.Acc Chem Res,2003,36(11):807-811.
    [2] Stephen RW.Biological aspects of fullerenes.In:Karl MK.Rodney SR.Fullerenes:chemistry,physics and technology.New York:John Wiley Sons,2000.437-465.
    [3] Tabata Y,Murakami Y,Ikada Y.Photodynamic effect of polyethylene glycol modified fullerene on tumor.Jpn J Cancer Res,1997,88(11):1108-1116.
    [4] Qingnuan L,Yan X,Xiaodong Z,et al.Preparation of (99m)Tc-C(60)(OH)(x) and its biodistribution studies.Nucl Med Biol,2002,29(6):707-710.
    [5] Simon HF,Dianne LD,Rint PS,et al.Inhibition of the HIV-1 Protease by fullerene derivatives:model building studies and experimental verification.J Am Chem Soc,1993,115:6506-6509.
    [6] David IS,Stephen RW.Raymond FS.Anti-human immunodeficiency virus activity and cytotoxicity of derivatized buckminsterfullerenes.Bioorg Med Chem Let,1996,6(11):1253-1256.
    [7] Sijbesma R,Srdanov G,Wudl F,et al.Synthesis of a fullerene derivative for the inhibition of HIV enzymes.J Am Chem Soc,1993,115:6510-6512.
    [8] Rajagopalan P,Wudl F,Schinazi RF,et al.Pharmacokinetics of a water-soluble fullerene in rats.Antimicrob Agents Chemother,1996,40(10):2262-2265
    [9] Zhu Z,Schuster DI,Tuckerman ME.Molecular dynamics study of the connection between flap closing and binding of fullerene-based inhibitors of the HIV-1 protease.Biochemistry,2003,42(5):1326-1333.
    [10] Marchesan S,Da Ros T,Spalluto G,et al.Anti-HIV properties of cationic fullerene derivatives.Bioorg Med Chem Lett,2005,15(15):3615-3618.
    [11] Tatiana DR,Ester V,Giampiero S,et al.Design,synthesis and biological properties of fulleropyrrolidine derivatives as potential DNA photoprobes.J Supramol Chem,2002,2(1,3):327-334.
    [12] Yu L,Yan-Li Zh,Yong Ch,et al.A Water-soluble β-cycodextrin derivative possessing a fullerene tether as an efficient photodriven DNA-cleavage reagent.Tetra Lett,2005,46:2507-2511.
    [13] Arimondo PB,Moreau P,Boutorine A,et al.Recognition and cleavage of DNA by rebeccamycin-or benzopyridoquinoxaline conjugated of triple helix-forming oligonucleotides.Bioorg Med Chem,2000,8(4); 777-784.
    [14] Imahori H,Fukuzumi S.Porphyrin and fullerene-based photovoltaic devices.Advanced Functional Materials,2004,14(6):525-536.
    [15] Krusic PJ,Wasscerman E,Keizer PN,et al.Radical reactions of C60.Science,1991,254(5035):1183-1185.
    [16] Dugan LL,Turetsky DM,Du C,et al.Carboxyfullerenes as neuroprotective agents.Proc Natl Acad Sci USA,1997,94(17):9434-9439.
    [17] Corona-Morales AA,Castell A,Escobar A,et al.Fullerene and ascorbic acid protect cultured chromaffin cells against levodopa toxicity.J Neurosci Res,2003,71(1):121-126.
    [18] Shuying Liu,Shuqing Sun,Recent progress in the studies of endohedreal metallofullerenes.J Organometal Chem,2000,599:75-86
    [19] Wharton T,Wilson LJ.Highly-iodinated fullerene as a contrast agent for X-ray imaging.Bioorg Med Chem,2002,10(11):3545-3554.
    [20] Bolskar RD,Benedetto AF,Husebo LO,et al.First soluble M@C60 derivatives provide enhanced access to metallofullerenes and permit in vivo evaluation of Gd@C60[C(COOH)2]10 as a MRI contrast agent.J Am Chem Soc,2003,125(18):5471-5478.
    [21] Toth E,Bolskar RD,Borel A,et al.Water-soluble gadofullerenes:toward high-relaxivity,pH-responsive MRI contrast agents.J Am Chem Soc,2005,127(2):799-805.
    [22] Xenogiannopoulou E,Couris S,Koudoumas E,et al.Nonlinear optical response of some isomerically pure higher fullerenes and their corresponding endohedral metallofullerene derivatives:C82-C2v,Dy@C82(Ⅰ),Dy2@C82(Ⅰ),C92-C2 and Er2@C92(Ⅳ).Chem Phy Lette,2004,394(1):14-18.
    [23] Watanabe S,Ishioka NS,Shimomura H,et al.Synthesis of hydrophilic endohedral 133Xe-fullerenol with high yield.JAERI(Japan Atomic Energy Research Institute) Review,2004,25(11):248-249.
    [24] Cagle DW,Kennel S J,Mirzadeh S,et al.In vivo studies of fullerenebased materials using endohedral metallofullerene radiotracers.Proc Natl Acad Sci USA,1999,96(9):5182-5187.
  • [1] 孙权蔡建明黄越承 . 富勒烯衍生物对自由基的清除作用及其生物学效应. 国际放射医学核医学杂志, 2008, 32(5): 308-311.
    [2] 侯震李双双闫婧 . 影像组学与深度学习在肿瘤放疗中的研究进展. 国际放射医学核医学杂志, 2020, 44(12): 744-749. doi: 10.3760/cma.j.cn121381-202004004-00107
    [3] 董庆玉陈丽 . 骨髓间充质干细胞的活体标记示踪技术及其研究进展. 国际放射医学核医学杂志, 2007, 31(5): 314-317.
    [4] 刘谦白志杰伊晓勇 . 前列腺癌miRNA生物标志物及其与辐射敏感性的研究进展. 国际放射医学核医学杂志, 2017, 41(3): 227-231. doi: 10.3760/cma.j.issn.1673-4114.2017.03.013
    [5] 石景芳王迎春陈宏徐荣李雪霞 . 移植肾输尿管梗阻伴结石1例报告并文献复习. 国际放射医学核医学杂志, 2008, 32(5): 319-320.
    [6] 马铁军王毅杨莹冯伟李冕 . 蛋白标志物在辐射损伤中的应用. 国际放射医学核医学杂志, 2010, 34(3): 179-182. doi: 10.3760/cma.j.issn.1673-4114.2010.03.015
    [7] Caride VJ . 放射性标记脂质体在诊断显像中应用的技术和生物学问题. 国际放射医学核医学杂志, 1990, 14(4): 180-182.
    [8] 赵竞张占文马慧聂大红蒋宁一刘生唐刚华 . PET/CT显像剂18F-氟丙酸在肝癌中的生物学评估. 国际放射医学核医学杂志, 2018, 42(5): 414-419. doi: 10.3760/cma.j.issn.1673-4114.2018.05.005
    [9] 刘芬菊 . 氚标记化合物在放射生物学基础与应用中的研究进展. 国际放射医学核医学杂志, 2023, 47(10): 638-641. doi: 10.3760/cma.j.cn121381-202309016-00362
    [10] 江口精美陈文霞 . 氚的生物学效应. 国际放射医学核医学杂志, 1980, 4(1): 40-41.
    [11] 罗祖玉 . 肿瘤放射生物学. 国际放射医学核医学杂志, 1984, 8(2): 85-88.
  • 加载中
计量
  • 文章访问数:  1084
  • HTML全文浏览量:  99
  • PDF下载量:  4
出版历程
  • 收稿日期:  2005-04-25

富勒烯及其衍生物在核生物医学领域应用的研究现状

  • 1. 200433 上海, 第二军医大学放射医学教研室;
  • 2. 200433 上海, 第二军医大学药学院有机化学教研室
基金项目:  国家自然科学基金资助项目(30200069)

摘要: 富勒烯及其衍生物是一类具有独特物理化学特性的化合物,在生物医学领域有广泛的应用前景。介绍该类化合物的合成及制备,富勒烯笼外配合物的抗HIV病毒、断裂DNA和清除自由基等生物学活性,以及富勒烯金属包合物在核医学诊断中的应用研究。

English Abstract

参考文献 (24)

目录

    /

    返回文章
    返回